Bioflight A/S: Financial statements 2012
CVR: 67021614
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Bioflight A/S (CVR 67021614) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,878,976 and a net result of DKK 1,276,057. Equity in the 2012 report amounted to DKK 2,449,349. The solvency ratio was 81.7%.
- Gross Profit
- DKK 1,878,976
- Profit/Loss
- DKK 1,276,057
- Equity
- DKK 2,449,349
- Total Assets
- DKK 2,999,526
Official annual report
Keep an eye on Bioflight A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 14, 2012, Henrik Smith has joined the board of directors of Bioflight A/S.
As of December 14, 2012, Jørn Asmussen has left the board of directors of Bioflight A/S.
As of February 15, 2012, Jørn Asmussen has joined the board of directors of Bioflight A/S.
As of February 15, 2012, Martin Risby Birk has left the board of directors of Bioflight A/S.
About Bioflight A/S
Bioflight A/S is a Danish company of the type Aktieselskab based in Roskilde, founded in 1981. The company is registered under the industry Anden teknisk rådgivning. The company was previously named BIO.FLIGHT A/S and BIO/CONSULT A/S. The management consists of Mads Peter Jepp Brandt. The board consists of Roar Bendix Engmann (chair), Erling Dyrmose, Henrik Røboe Dam and Mads Peter Jepp Brandt. The company's owners include Mads Peter Jepp Brandt, Anders Brandt Petersen and Anne-Sofie Hohl. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 20,922,915 and a net result of DKK 8,567,469 compared with DKK 8,007,856 the year before. Equity in the 2025 report amounted to DKK 35,450,222.
